VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The need for new treatment strategies for patients with DLBCL

Umberto Vitolo, MD, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy, discusses treatment strategies in diffuse large B-cell lymphoma (DLBCL), highlighting the unmet need in this area. Prof. Vitolo first explains how treatment approaches have not advanced over the years, and then highlights the potential value of polatuzumab vedotin in this space. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter